Flucon

Fluconazole

Method of action: Antifungal Broad Spectrum

Treatment option: Balanitis, Vaginal Candidiasis, Histoplasmosis, Fungal Infection, Fungal Infection,Fingernail, Jock Itch, Immunodeficiency, Infection, Candidemia, Candidiasis,Vaginal

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Flucon

What is Flucon?

Flucon is an ophthalmic corticosteroid solution used to treat certain inflammatory conditions of the eye. It contains fluorometholone, a synthetic glucocorticoid that helps to reduce the physical symptoms of inflammation, such as swelling, redness, and irritation.

Mechanism of Action

The active ingredient in Flucon works by mimicking the effects of naturally occurring hormones in the body that suppress the immune response. When applied directly to the eye, it inhibits the release of substances that cause inflammation. This localized action helps to manage the body's overactive response to injury or irritation without affecting the rest of the body to the same degree as systemic steroids.

Therapeutic Indications

Flucon is primarily utilized for the treatment of responsive inflammatory conditions affecting the external and anterior segments of the eye. These conditions may include:

Allergic Conjunctivitis: Inflammation caused by allergens such as pollen or pet dander.
Scleritis and Episcleritis: Inflammation of the white outer coating of the eye or the layer just above it.
Cyclitis and Uveitis: Inflammation of the middle layers of the eye.
Post-operative Inflammation: Managing redness and swelling following ocular surgery.
Physical Injury: Recovery from chemical, radiation, or thermal burns, or penetration of foreign bodies.

By addressing the underlying inflammatory process, Flucon assists in relieving discomfort and protecting ocular tissues from damage associated with prolonged inflammation.

Regulatory References

WHO List of Essential Medicines

What side effects are possible with Flucon?

Possible side effects and safety information

Fluconazole's official safety profile, as classified by government regulatory authorities, details the spectrum of potential adverse reactions based on their frequency and the affected physiological system.

Frequency-Classified Adverse Reactions

Adverse effects are categorized to communicate risk based on occurrence rates documented in regulatory labeling, such as the FDA Prescribing Information and the EMA SmPC.

Frequency	Examples of Officially Listed Adverse Reactions
Common	Headache, Nausea, Abdominal pain, Diarrhea, Vomiting, Rash, Elevated liver enzymes (ALT/AST).
Uncommon	Anemia, Dizziness, Insomnia, Seizures, Constipation, Myalgia (muscle pain).
Rare	Anaphylaxis, Hepatic failure, Agranulocytosis, QT interval prolongation, Torsades de Pointes.

Systemic and Serious Safety Considerations

The most frequently affected organ classes include the Gastrointestinal and Nervous systems. Of critical importance are the Serious Adverse Reactions documented in official labeling. These include the potential for Severe Hepatotoxicity and Hepatic Failure, Exfoliative Cutaneous Reactions (e.g., Stevens-Johnson Syndrome), and serious Cardiac Arrhythmias (e.g., QT interval prolongation), which are rare but require specific safety attention.

Population-Specific Safety

Specific safety considerations exist for certain groups. The safety profile notes that Fluconazole clearance is affected by Renal Impairment, potentially requiring adjustment based on official guidance. Caution is also detailed for patients with Severe Hepatic Impairment and those with pre-existing risk factors for Cardiac QT Prolongation. Its use is formally restricted in individuals with known Hypersensitivity to Fluconazole or other azole antifungals.

Overdose and Emergency Response

Overdose and When to Seek Help

The primary concern in cases of Flucon (fluconazole) overdose is acute toxicity, which can lead to serious central nervous system and gastrointestinal effects, as described in official regulatory documents.

Documented Overdose Risks

System Affected	Official Overdose Manifestations
Central Nervous System	Hallucination, paranoid behavior
Gastrointestinal	Severe vomiting, diarrhea, stomach pain
Renal	Potential for crystalluria and impaired kidney function (based on known toxicity profile)

Massive ingestion, such as the reported case of 8200 mg, has been associated with severe manifestations, including hallucination and paranoid behavior. Furthermore, animal studies involving very high doses have shown the potential for convulsions or seizures.

Required Emergency Actions

Immediate medical attention is required in all cases of suspected Flucon overdose. You must contact a health care practitioner, hospital emergency department, or regional Poison Control Centre immediately, even if no symptoms are present.

Management of overdose is primarily symptomatic and supportive. Because Flucon is largely excreted by the kidneys, procedures like gastric lavage may be considered if clinically indicated. A three-hour session of hemodialysis has been shown to decrease the amount of Flucon in the blood plasma by approximately 50%, providing an official method for reducing systemic exposure in severe cases.

Therapeutic Uses of Flucon

What Flucon Treats: Main Uses and Benefits

Fluconazole is commonly used across conditions presenting with systemic or localized discomfort caused by yeast and other fungi. It is applied in clinical settings that involve acute or unstable symptom patterns, including the management of serious, deep-seated infections like candidemia and cryptococcal meningitis, as well as superficial manifestations such as oral thrush, esophageal candidiasis, and vaginal yeast infections. The medicine is considered relevant when short-term symptomatic assistance is needed, such as in high-risk, immunocompromised patient groups.

The medication may be part of symptomatic management applied across domains where additional symptomatic support is needed, assisting with managing symptoms that interfere with daily comfort. This approach is used when symptoms create noticeable physiological strain, which offers symptomatic relief that helps patients cope more steadily with difficult episodes.

“The medication is a relevant tool in scenarios requiring supportive symptom management against both superficial and invasive fungal disease.”

Quick Fact: Relief for Localized and Systemic Discomfort Fluconazole is used for managing symptoms related to inflammatory or irritative states of mucous membranes and systemic manifestations like fever associated with severe fungal infections.

Eligibility and Restrictions for Use

Population Eligibility and Contraindications

Fluconazole eligibility is strictly defined by regulatory bodies based on specific patient conditions and demographic factors. The medicine is absolutely contraindicated in patients with a documented hypersensitivity to Fluconazole, other azole antifungals, or any component of the formulation. Use is also prohibited when co-administered with specific CYP3A4-metabolized medicines that are known to prolong the QT interval (e.g., cisapride).

Conditional Use and Restrictions:

The medicine is not recommended for use during pregnancy due to a documented risk of congenital anomalies, particularly with chronic high-dose exposure, and use in lactating women requires caution. Conditional use applies to patients with pre-existing hepatic impairment or impaired renal function, requiring caution due to effects on drug clearance and safety profile. In the pediatric population, safety and effectiveness for genital candidiasis have not been established, though the medicine is approved for most other systemic and mucosal infections. Older adults must be assessed for age-related decline in renal function.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Fluconazole (Flucon) is a known strong inhibitor of Cytochrome P450 enzymes CYP2C9 and CYP2C19, and a moderate inhibitor of CYP3A4. This mechanism slows the body's breakdown of many co-administered medicines, which can lead to dangerously high levels of those drugs and an increased risk of adverse effects.

Contraindicated Combinations

Certain combinations are strictly contraindicated and must not be used together due to the potential for severe, life-threatening heart rhythm changes (QT prolongation and Torsades de Pointes). These include co-administration with medicines such as cisapride, pimozide, and quinidine.

Combinations Requiring Close Monitoring

The following drug categories and specific medicines require dose adjustment and/or close clinical and laboratory monitoring when taken with fluconazole:

Anticoagulants (e.g., warfarin): Increases the risk of bleeding; necessitates careful monitoring of the International Normalized Ratio (INR).
Oral Hypoglycemics (e.g., glipizide, glyburide): Increases the risk of low blood sugar; requires blood glucose monitoring.
Immunosuppressants (e.g., cyclosporine, tacrolimus): Increases drug concentration; requires therapeutic drug monitoring.
Statins (e.g., atorvastatin, simvastatin): Increases the risk of muscle damage (rhabdomyolysis); may require dose reduction of the statin.
Rifampin: Decreases fluconazole concentration, potentially reducing its effect.

Other interacting medicines include certain antidepressants (e.g., citalopram, amitriptyline), antiepileptics (e.g., phenytoin), and opioids (e.g., fentanyl). For women of child-bearing potential taking high-dose fluconazole, effective contraception should be considered during treatment and for approximately one week after the last dose.

Mechanism of Action

How Flucon Works

Fluconazole's mechanism is defined by its selective molecular interaction within the fungal cell. The drug acts as a highly specific inhibitor of the fungal enzyme lanosterol 14-alpha-demethylase (CYP51), a crucial cytochrome P450 enzyme. The inhibition immediately blocks the ergosterol biosynthesis pathway by preventing the conversion of lanosterol into the vital structural component ergosterol.

This blockade initiates a dual cellular defect: a profound depletion of ergosterol and the concurrent accumulation of toxic 14-alpha-methylated sterols within the fungal cell. This resulting sterol imbalance fatally compromises the cell membrane's structural integrity and permeability, which results in the arrest of fungal growth and replication (fungistatic activity) and compromises the capacity of the organism for proliferation.

The mechanism exhibits high mechanistic selectivity for the fungal target, and the drug demonstrates minimal affinity for human P450 systems. However, the mechanism can be constrained in fungi that develop resistance, typically through mutations that reduce drug binding or by the overexpression of active efflux pumps that transport the drug out of the cell, preventing it from reaching inhibitory concentrations at the target.

Dosage and Administration Information

How Fluconazole is Used: Official Administration Guidelines

The usage of Fluconazole is structured around specific rules detailing the administration route, dosing schedule, and required adjustments. The medicine is available for both oral administration (capsules, tablets, or suspension) and intravenous (IV) infusion. Due to its high absorption rate, the prescribed daily dose remains consistent whether it is administered orally or intravenously.

Official Dosing and Administration Structure

The treatment course often begins with a loading dose on the first day, which is typically double the maintenance dose. This strategy ensures the concentration of the medicine in the bloodstream reaches effective levels more quickly. Following this initiation, the standard maintenance frequency for most indications is once daily.

Treatment duration varies significantly by condition, ranging from a single dose for certain acute fungal infections to several weeks, or even indefinitely for long-term suppressive therapy in high-risk patients (e.g., to prevent relapse of cryptococcal meningitis). Oral forms may be taken with or without food.

Required Procedural Adjustments

Official labeling requires specific adjustments for administration:

Renal Impairment: The dose must be adjusted for patients with reduced kidney function (creatinine clearance le 50 mL/min). Patients undergoing hemodialysis should receive 100% of the recommended daily dose immediately following the dialysis session.
Pediatric Dosing: Doses for children are calculated based on body weight (mg/kg), with the maximum daily dose limited to 400 mg.
IV Infusion Rate: When administered intravenously, the sterile solution must be infused slowly at a rate that does not exceed 10 mL per minute.

These instructions define a standardized protocol focused purely on the logistical steps for accurate dosing and administration.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Flucon

This overview summarizes the available research landscape for Fluconazole, detailing what has been studied, the populations involved, and where scientific uncertainty may still exist, based on authoritative reports and peer-reviewed literature.

Evidence for Use in Systemic and Invasive Infections (Candidiasis and Cryptococcosis)

Research exploring Fluconazole in the context of severe systemic fungal diseases, such as Invasive Candidiasis (e.g., Candidemia) and Cryptococcal Meningitis, primarily includes Randomized Controlled Trials (RCTs) and comprehensive systematic reviews. These studies were designed to track measurements of patient survival and the speed and rate of microbiological clearance that was measured from the blood or other affected sites, such as the cerebrospinal fluid (CSF) for Cryptococcal Meningitis.

Research on Endpoints and Comparator Trials

Studies examining Invasive Candidiasis focused on populations that were often critically ill or post-surgical, monitoring outcomes related to systemic or functional imbalance that were evaluated in the studies over observation periods typically lasting weeks to months. The studies explored patterns observed in these populations, often including Fluconazole in research that featured other systemic antifungal options as comparators. For Cryptococcal Meningitis, research was often conducted in high-risk patients, including those with HIV/AIDS, to examine outcomes related to fungal-free survival and the control of the infection in the central nervous system.

Evidence for Preventing Fungal Infections (Prophylaxis)

Research has widely explored Fluconazole in the context of prophylaxis, focusing on patterns of fungal infection development in high-risk individuals. The design of these studies often utilized placebo-controlled RCTs and Meta-Analyses to assess whether the use of Fluconazole related to the risk of developing an Invasive Fungal Infection (IFI) in patients who are severely immunocompromised.

Study populations have included patients undergoing intensive chemotherapy or Hematopoietic Stem Cell Transplant (HSCT), as well as Very Low Birth Weight (VLBW) preterm infants. Research examined the frequency of IFI occurrence and rates of fungal colonization in the observed groups.

Long-term Follow-up and Maintenance Therapy Studies

Research has explored the long-term use of Fluconazole, particularly for maintenance therapy, where studies tracked patterns of relapse of serious conditions like Cryptococcal Meningitis and recurrence in vaginal candidiasis. Studies on long-term prophylaxis for conditions like Cryptococcal Meningitis in high-risk groups have used extended follow-up durations, monitoring patients for years to track patterns of recurrence or relapse. However, long-term effects are not fully established for all outcomes, and data are still emerging, particularly regarding the full implications of continuous exposure on the development of fungal resistance across populations.

Key Studies & References

Frequently Asked Questions (FAQ)

Common questions about Flucon (FAQ)

Q: Does Flucon interact with pain relievers like ibuprofen?

Regulatory information indicates that Fluconazole may interact with a group of pain relievers called Nonsteroidal Anti-inflammatory Drugs (NSAIDs), which includes ibuprofen. This interaction can lead to an increase in the NSAID's concentration in the body. If co-administration is necessary, it is important that a healthcare professional is aware of all co-administered medications.

Q: Can Flucon affect birth control pills?

Official drug interaction studies have shown that fluconazole, when taken at certain daily doses, can increase the levels of the active components in some hormonal contraceptives, specifically ethinyl estradiol and levonorgestrel. This change in concentration is noted in the official product information.

Q: What are the signs of a severe allergic reaction to Flucon?

Signs that may indicate a severe or serious reaction include exfoliative skin disorders, which means severe rash or blistering, and swelling of the face or throat. Other serious symptoms include signs of liver damage, such as yellowing of the skin or eyes (jaundice), or persistent nausea and dark urine. If these or other severe symptoms occur, immediate medical attention is necessary.

Q: Can Flucon affect blood sugar levels?

Yes, regulatory documents describe an interaction with certain diabetes medications. Fluconazole reduces the rate at which the body breaks down specific oral hypoglycemic agents (a class of medicines like sulfonylureas). This change requires careful blood glucose monitoring.

Q: Does Flucon have long-term side effects?

Though data on very long-term effects is limited, high-dose or prolonged use of fluconazole has been associated with specific adverse events. These include a rare risk of serious hepatic (liver) toxicity. Additionally, hair loss, medically known as alopecia, has been noted and is typically reversible upon cessation of treatment.

Q: What happens if Flucon does not seem to be effective?

If the symptoms being treated do not show improvement, or if they appear to worsen during the course of the medication, official patient information states that a healthcare professional should be consulted. Any changes to treatment duration should be determined by a healthcare professional.

Q: Is it normal to feel dizzy when starting Flucon?

Dizziness is listed in official adverse reaction documents as a common side effect that may occur while using the medication. This effect should be considered, especially when engaging in activities that require full concentration.

Q: What symptoms might indicate that Flucon is causing a serious problem?

Symptoms that may indicate a serious problem include an irregular heartbeat, severe dizziness, or fainting. Other serious signs include the onset of a severe skin reaction or any symptoms pointing toward potential liver issues, such as extreme fatigue or jaundice. If severe or persistent fatigue occurs, a healthcare professional should be informed.

Q: How quickly should someone expect Flucon to start working?

According to the official pharmacokinetic data, the concentration of the drug reaches its highest level in the blood plasma (peak concentration) between 1 and 2 hours after a person takes an oral dose.

Q: What happens if a dose of Flucon is missed?

Official patient instructions recommend that if a dose is missed, it should be taken as soon as it is remembered. However, if it is almost time for the next scheduled dose, the missed dose should be skipped to prevent accidentally taking two doses too close together.

Q: Can Flucon cause changes in appetite?

While minor changes are not typically listed, severe loss of appetite (anorexia) is noted in the official documentation. This symptom can be a sign of a rare but serious side effect, such as liver toxicity or adrenal insufficiency. If persistent, a healthcare professional should be consulted.

Q: Does alcohol consumption impact Flucon's effectiveness?

Regulatory and general medical guidance does not list alcohol as a direct pharmacological interaction that reduces the drug's effectiveness. However, consuming alcohol may worsen common adverse reactions, such as headaches, nausea, and dizziness, and can place additional stress on the liver.

Q: Can I drive or operate machinery while taking Flucon?

Official warnings state that occasional side effects such as dizziness or fits (seizures) may occur while taking Flucon. Because of this potential risk, caution is advised before engaging in activities that require alertness, such as driving or operating machinery.

Q: Is it common to feel tired while taking Flucon?

Tiredness (fatigue) is a reported adverse reaction. In some cases, extreme or persistent tiredness can also be an early sign of a more serious, rare side effect, such as adrenal insufficiency. If severe or worsening fatigue occurs, a healthcare professional should be informed.

Q: If I feel better, can I stop taking Flucon early?

Official patient information recommends that the medication should be taken for the entire duration prescribed by a healthcare professional, even if symptoms improve quickly. Stopping treatment early can increase the risk of the infection returning or developing resistance to the drug.

Q: Are there different strengths or forms of Flucon available?

According to official labeling, fluconazole is available in several dosage forms. These include various strengths of oral tablets (e.g., 50 mg, 150 mg, 200 mg), a powder used to create an oral suspension (liquid), and a sterile solution suitable for intravenous use.

Q: How is Flucon removed from the body?

The drug is primarily eliminated from the body through the renal system (the kidneys). Official pharmacokinetic data states that approximately 80% of the dose is passed out of the body through the urine as the unchanged, active drug.

Q: What is the expected duration of action after the last dose of Flucon?

The official pharmacokinetic information for fluconazole indicates that the average half-life in the plasma is approximately 30 hours. The half-life is the time it takes for the concentration of the medicine in the blood to decrease by half.

Q: What should I know about taking Flucon with antacids?

Interaction studies have specifically evaluated the co-administration of oral fluconazole and antacids. The official product information states that there is no clinically significant impairment of fluconazole absorption when these two types of medications are taken together.

How should Flucon be stored and disposed of?

The storage and disposal of fluconazole must adhere strictly to regulatory conditions to ensure stability and safety.

Official Storage Conditions

Fluconazole Tablets and Dry Powder must be stored at or below 30 C (86 F). The dry powder and the reconstituted oral suspension must be protected from freezing. Once mixed, the suspension is stable for only 14 days and must be stored between 5 C (41 F) and 30 C (86 F) before being discarded.

Handling and Disposal

All forms of the medicine must be kept out of the sight and reach of children. Unused or expired fluconazole must be disposed of according to local and national regulations and should not be released into the environment or wastewater.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.